Follistatin during pregnancy and its potential role as an ovarian suppressing agent

Objective Ovarian quiescence is a common condition during pregnancy. In vitro, follistatin, an antagonist of follicle-stimulating hormone, blocks follicular development at early stages, and its serum levels increase during pregnancy. A possible surrogate biomarker of ovarian arrest during pregnancy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Köninger, Angela (VerfasserIn) , Strowitzki, Thomas (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: May 2017
In: European journal of obstetrics & gynecology and reproductive biology
Year: 2017, Jahrgang: 212, Pages: 150-154
ISSN:1872-7654
DOI:10.1016/j.ejogrb.2017.03.001
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/j.ejogrb.2017.03.001
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0301211517301045
Volltext
Verfasserangaben:Angela Köninger, Börge Schmidt, Daniela Damaske, Cahit Birdir, Antje Enekwe, Rainer Kimmig, Thomas Strowitzki, Alexandra Gellhaus

MARC

LEADER 00000caa a2200000 c 4500
001 1582520364
003 DE-627
005 20220815044632.0
007 cr uuu---uuuuu
008 181102s2017 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ejogrb.2017.03.001  |2 doi 
035 |a (DE-627)1582520364 
035 |a (DE-576)512520364 
035 |a (DE-599)BSZ512520364 
035 |a (OCoLC)1341022141 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Köninger, Angela  |d 1976-  |e VerfasserIn  |0 (DE-588)123908736  |0 (DE-627)085517534  |0 (DE-576)293937710  |4 aut 
245 1 0 |a Follistatin during pregnancy and its potential role as an ovarian suppressing agent  |c Angela Köninger, Börge Schmidt, Daniela Damaske, Cahit Birdir, Antje Enekwe, Rainer Kimmig, Thomas Strowitzki, Alexandra Gellhaus 
264 1 |c May 2017 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 02.11.2018 
520 |a Objective Ovarian quiescence is a common condition during pregnancy. In vitro, follistatin, an antagonist of follicle-stimulating hormone, blocks follicular development at early stages, and its serum levels increase during pregnancy. A possible surrogate biomarker of ovarian arrest during pregnancy is a decrease in anti-mullerian hormone (AMH) levels followed by an increase in these levels on the second day after labor. The purpose of this study was to determine whether follistatin could act as an ovarian-suppressing agent during pregnancy. Follistatin levels and AMH levels were determined at various stages of pregnancy and postpartum. Study design The follistatin and AMH levels of 69 patients were retrospectively determined with the AMH Gen II ELISA and with the Human Follistatin Quantikine ELISA Kit. For 49 patients, samples were available from various trimesters for cross-sectional analysis; for the other 20, samples were available longitudinally from day one before labor and then daily on days 1 through 4 after labor. Statistical significance was determined with linear regression, the Friedman rank sum test and the Wilcoxon-Nemenyi-McDonald-Thompson post hoc test. Results The behavior of follistatin levels was exactly opposite that of AMH levels: Follistatin levels increased significantly during pregnancy and on the first day after parturition but declined afterwards, whereas AMH levels decreased significantly during pregnancy and increased after labor. Conclusion Follistatin can induce ovarian arrest during pregnancy. 
650 4 |a Anti-mullerian hormone 
650 4 |a Follistatin 
650 4 |a Ovarian quiescence 
650 4 |a Pregnancy 
700 1 |a Strowitzki, Thomas  |d 1959-  |e VerfasserIn  |0 (DE-588)118055917  |0 (DE-627)079216099  |0 (DE-576)17102141X  |4 aut 
773 0 8 |i Enthalten in  |t European journal of obstetrics & gynecology and reproductive biology  |d Amsterdam [u.a.] : Elsevier Science, 1973  |g 212(2017), Seite 150-154  |h Online-Ressource  |w (DE-627)320443469  |w (DE-600)2005196-7  |w (DE-576)094142106  |x 1872-7654  |7 nnas  |a Follistatin during pregnancy and its potential role as an ovarian suppressing agent 
773 1 8 |g volume:212  |g year:2017  |g pages:150-154  |g extent:5  |a Follistatin during pregnancy and its potential role as an ovarian suppressing agent 
856 4 0 |u http://dx.doi.org/10.1016/j.ejogrb.2017.03.001  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0301211517301045  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20181102 
993 |a Article 
994 |a 2017 
998 |g 118055917  |a Strowitzki, Thomas  |m 118055917:Strowitzki, Thomas  |d 910000  |d 910400  |e 910000PS118055917  |e 910400PS118055917  |k 0/910000/  |k 1/910000/910400/  |p 7 
999 |a KXP-PPN1582520364  |e 3030221334 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 02.11.2018"],"origin":[{"dateIssuedDisp":"May 2017","dateIssuedKey":"2017"}],"title":[{"title":"Follistatin during pregnancy and its potential role as an ovarian suppressing agent","title_sort":"Follistatin during pregnancy and its potential role as an ovarian suppressing agent"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"person":[{"display":"Köninger, Angela","family":"Köninger","role":"aut","given":"Angela"},{"family":"Strowitzki","display":"Strowitzki, Thomas","given":"Thomas","role":"aut"}],"id":{"eki":["1582520364"],"doi":["10.1016/j.ejogrb.2017.03.001"]},"relHost":[{"disp":"Follistatin during pregnancy and its potential role as an ovarian suppressing agentEuropean journal of obstetrics & gynecology and reproductive biology","language":["eng"],"note":["Gesehen am 20.11.24","Ungezählte Beil.: Supplement"],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"publisherPlace":"Amsterdam [u.a.]","dateIssuedDisp":"1973-","publisher":"Elsevier Science","dateIssuedKey":"1973"}],"title":[{"title":"European journal of obstetrics & gynecology and reproductive biology","title_sort":"European journal of obstetrics & gynecology and reproductive biology","subtitle":"the official journal of the European Association of Gynaecologists and Obstetricians (EAGO) & the European College of Obstetrics and Gynaecology (EBCOG)"}],"part":{"volume":"212","extent":"5","pages":"150-154","text":"212(2017), Seite 150-154","year":"2017"},"pubHistory":["3.1973 -"],"recId":"320443469","physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1872-7654"],"eki":["320443469"],"zdb":["2005196-7"]}}],"physDesc":[{"extent":"5 S."}],"name":{"displayForm":["Angela Köninger, Börge Schmidt, Daniela Damaske, Cahit Birdir, Antje Enekwe, Rainer Kimmig, Thomas Strowitzki, Alexandra Gellhaus"]},"recId":"1582520364"} 
SRT |a KOENINGERAFOLLISTATI2017